ProCE Banner Activity

A Pharmacologic View of Tardive Dyskinesia: Pathology and Treatment

Slideset

This downloadable slideset revisits the mechanism of action, molecular differences, and PK/PD of VMAT2 inhibitors. Clinical considerations for safety and efficacy in older patient populations as they relate to dosing/titration schedules in special populations with age-related changes in body composition, metabolism, and comorbidities are discussed.

Released: November 27, 2024

Expiration: November 26, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc.